[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Boston Scientific Corp (BSX) - Financial and Strategic SWOT Analysis Review

April 2021 | 75 pages | ID: B020B431A8DEN
GlobalData

US$ 125.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Boston Scientific Corp (BSX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Boston Scientific Corp (Boston Scientific) is a medical technology company that develops, manufactures and commercializes devices for a range of interventional medical specialties. The company offers products in the areas of electrophysiology, gastroenterology, gastrointestinal surgery, female pelvic medicine, gynecology, interventional cardiology, interventional radiology, neurological surgery, orthopedic surgery, pain medicine, pulmonology, urology and vascular surgery. Boston Scientific serves hospitals, clinics, outpatient facilities and medical offices across the world. The company has manufacturing facilities in the US, Ireland, Costa Rica, Brazil, Malaysia, Puerto Rico and Switzerland. It sells products directly and also through a network of distributors and dealers in Europe, the Middle East, Africa, Asia Pacific and the Americas. Boston Scientific is headquartered in Marlborough, Massachusetts, the US.

Boston Scientific Corp Key Recent Developments

Mar 26,2021: Boston Scientific Announces Conference Call Discussing First Quarter 2021 Results and Participation in Truist Securities 2021 Life Sciences Summit
Mar 24,2021: Boston Scientific to pay US states for deceptive mesh devices marketing
Mar 04,2021: Boston Scientific to acquire Lumenis’ surgical business for $1.07bn
Mar 03,2021: Baring Private Equity Asia Announces Agreement to Sell Lumenis' Surgical Business to Boston Scientific for USD1.07 billion
Feb 12,2021: Boston Scientific Announces February and March 2021 Conference Schedule

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Boston Scientific Corp - Key Facts
Boston Scientific Corp - Key Employees
Boston Scientific Corp - Key Employee Biographies
Boston Scientific Corp - Major Products and Services
Boston Scientific Corp - History
Boston Scientific Corp - Company Statement
Boston Scientific Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Boston Scientific Corp - Business Description
Business Segment: Cardiovascular
Overview
Performance
Business Segment: MedSurg
Overview
Performance
Business Segment: Rhythm and Neuro
Overview
Performance
Business Segment: Specialty Pharmaceuticals
Overview
Performance
Geographical Segment: APAC (Asia-Pacific)
Performance
Geographical Segment: EMEA (Europe, Middle East and Africa)
Performance
Geographical Segment: International
Performance
Geographical Segment: LACA (Latin America and Canada)
Performance
Geographical Segment: U.S.
Performance
R&D Overview
Boston Scientific Corp - Corporate Strategy
Boston Scientific Corp - SWOT Analysis
SWOT Analysis - Overview
Boston Scientific Corp - Strengths
Boston Scientific Corp - Weaknesses
Boston Scientific Corp - Opportunities
Boston Scientific Corp - Threats
Boston Scientific Corp - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Boston Scientific Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Boston Scientific Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
Boston Scientific Corp, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Mar 26, 2021: Boston Scientific Announces Conference Call Discussing First Quarter 2021 Results and Participation in Truist Securities 2021 Life Sciences Summit
Mar 24, 2021: Boston Scientific to pay US states for deceptive mesh devices marketing
Feb 12, 2021: Boston Scientific Announces February and March 2021 Conference Schedule
Feb 03, 2021: Boston Scientific announces results for fourth quarter and full year 2020
Jan 12, 2021: Boston Scientific announces preliminary unaudited sales for the fourth quarter and full year 2020
Dec 14, 2020: Boston Scientific announces stipulation of dismissal of Nevro Corporation's patent infringement case in California
Dec 02, 2020: Boston Scientific to sell BTG Specialty Pharmaceuticals business for $800m
Oct 28, 2020: Boston Scientific announces results for third quarter 2020
Sep 21, 2020: Boston Scientific signs agreement with option to acquire Farapulse
Aug 03, 2020: Boston Scientific: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Boston Scientific Corp, Key Facts
Boston Scientific Corp, Key Employees
Boston Scientific Corp, Key Employee Biographies
Boston Scientific Corp, Major Products and Services
Boston Scientific Corp, History
Boston Scientific Corp, Other Locations
Boston Scientific Corp, Subsidiaries
Boston Scientific Corp, Key Competitors
Boston Scientific Corp, Ratios based on current share price
Boston Scientific Corp, Annual Ratios
Boston Scientific Corp, Annual Ratios (Cont...1)
Boston Scientific Corp, Annual Ratios (Cont...2)
Boston Scientific Corp, Interim Ratios
Boston Scientific Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Boston Scientific Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
Boston Scientific Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Boston Scientific Corp, Performance Chart (2016 - 2020)
Boston Scientific Corp, Ratio Charts
Boston Scientific Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Boston Scientific Corp, Medical Equipment, Deals by Type, 2015 to YTD 2021


More Publications